RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
More outstanding work on COVID-19 vaccine effectiveness by the IVY network. Now with translational correlates!!! Double-doused MRNA vaccines are associated with higher vaccine effectiveness compared to the J&J shot. https://t.co/bJcjPXAOix
RT @PabloRichly: Una vez más la vacuna en monodosis de J&J se muestra bastante menos eficaz que las vacunas de 2 dosis para evitar cuadros…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @CarlosdelRio7: Turns out all vaccines are not equal! https://t.co/yP6eC6o78i via @CDCgov Among adults without immunocompromising condit…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @PabloRichly: Una vez más la vacuna en monodosis de J&J se muestra bastante menos eficaz que las vacunas de 2 dosis para evitar cuadros…
RT @masanpra: Estudio del CDC sobre vacunación en EEUU. Eficacia contra hospitalización en personas no inmunodeprimidas (marzo-agosto) Mod…
Estudio del CDC sobre vacunación en EEUU. Eficacia contra hospitalización en personas no inmunodeprimidas (marzo-agosto) Moderna 93% (92% >120 días tras 2 dosis) Pfizer 88% (77% >120 días tras 2 dosis) J&J 71% (68% >28 días )
Una vez más la vacuna en monodosis de J&J se muestra bastante menos eficaz que las vacunas de 2 dosis para evitar cuadros severos. https://t.co/Rlbusr9c8K
RT @CarlosdelRio7: Turns out all vaccines are not equal! https://t.co/yP6eC6o78i via @CDCgov Among adults without immunocompromising condit…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
More important work from our IVY Network. Proud to be a part of this smart and hardworking group collaborating with CDC.
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
@scienceismessy @CDCgov Sorry about that. Source is MMWR: https://t.co/O3Xzz7rbmW
ABD'li yetişkinlerin, 11 Mart-15 Ağustos 2021 tarihleri arasındaki izlemde COVID-19 nedeniyle hastaneye yatışlarını önlemede aşıların etkinliği; ✴ 2 doz Moderna aşısı %93 ✴ 2 doz Pfizer-BioNTech aşısı %88 ✴ 1 doz Janssen aşısı %71
@PedroFacon @DirkRamaekers @vanranstmarc @wbeke @neyts_johan Nieuw CDC rapport over vaccinefficiëntie. J&J beschermt 71% tegen hospitalisatie, dus veel minder goed dan de andere vaccins. Keer op keer komt J&J als slechtste uit de studies. Het word
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
We're going to have to get those booster shots queued up before the end of the year if this data holds.
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @CarlosdelRio7: Turns out all vaccines are not equal! https://t.co/yP6eC6o78i via @CDCgov Among adults without immunocompromising condit…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
Today's release from the #CDC "Protection for the Pfizer-BioNTech vaccine declined 4 months after vaccination" #COVID19 #vaccines #Pfizervaccine #PfizerBiontech #indoordining #MaskUp #MasksSaveLives https://t.co/njuqY3Id49
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
👇🧐
RT @dkohmoto: Vaccine effectiveness against COVID-19 hospitalization for U.S. adults without immunocompromising conditions: Moderna (93%) >…
Kinda seems like they should authorize boosters for J&J recipients!
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
A head to head CDC study of #COVID vaccine effectiveness against hospitalizations has shown that Moderna is the most effective (93%), followed by Pfizer-BioNTech (88%) and Janssen/J&J (71%). https://t.co/ov1ADAyeu5
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
A really important article comparing the three vaccines against Covid 19. https://t.co/KAgga3Sqki
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
CDC data on US vaccinations!
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
RT @EricTopol: New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised p…
New @CDCMMWR on US vaccinations, antibody (Ab) response, and protection from hospitalization (H) in non-immunocompromised people, March-August https://t.co/kvBoSzBkBd Vaccine Effectiveness vs H: Moderna 93%, Pfizer 88%, J&J 71% See Table below for det
RT @yaletung: Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospit…
While you're waiting for FDA advisory committee to vote on booster question, CDC is out with new study on comparative effectiveness of FDA authorized vaccines in spring to summer: https://t.co/UO1dcI7QWW https://t.co/14djDflQKv
Thanks, @BarneyGrahamMD @KizzyPhD @McLellan_Lab and the whole team
Comparative Effectiveness of Moderna (93%), Pfizer-BioNTech (88%), and Janssen (Johnson & Johnson, 71%) Vaccines (from CDC--Morbity & Mortality Weekly) https://t.co/a4dfXoZisJ
RT @AubreyNPR: How effective are #vaccines against #COVID19 hospitalization? Moderna = 93% effective Pfizer = 88% effective Janssen J&J…
Ça devrait vous intéresser @NGrandvaux et @VeilletteAndre. Il s’agit d’une étude sur l’efficacité, à long terme, des vaccins contre les hospitalisations. CC: @Roxane_ @RomainMartinIO @FrancoisAudet P.S. l’image provient du PDF publié par la CDC Lien : h
Considering getting your COVID vaccine and wondering which is most protective? All are good, but Moderna has a small advantage. Comparative Effectiveness of Moderna... https://t.co/gmoqvvNXsc via @CDCgov
RT @CarlosdelRio7: Turns out all vaccines are not equal! https://t.co/yP6eC6o78i via @CDCgov Among adults without immunocompromising condit…
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 https://t.co/UWY7XNmuU5 https:
Authors say the higher vaccine effectiveness of @moderna_tx vaccine "might be due to higher mRNA content in the Moderna vaccine" or differences in timing between doses (3 weeks for Pfizer-BioNTech versus 4 weeks for Moderna)
RT @SangkritiMajum1: NEW: @CDCMMWR under the supervision of @CDCgov directed by @CDCDirector shows killer shots will snatch away your price…
NEW: @CDCMMWR under the supervision of @CDCgov directed by @CDCDirector shows killer shots will snatch away your priceless life within 3 months. #COVID19 #nounethicalvaccine
RT @CarlosdelRio7: Turns out all vaccines are not equal! https://t.co/yP6eC6o78i via @CDCgov Among adults without immunocompromising condit…
RT @CarlosdelRio7: Turns out all vaccines are not equal! https://t.co/yP6eC6o78i via @CDCgov Among adults without immunocompromising condit…
How effective are #vaccines against #COVID19 hospitalization? Moderna = 93% effective Pfizer = 88% effective Janssen J&J = 71% according to this new analysis https://t.co/4Q5cYHzwk7 1/2
Comparative Effectiveness of Moderna... https://t.co/MWRRYoI8iO via @CDCgov
Another VE study by @CDCgov comparing all US authorized vaccines. The J&J efficacy against hospitalizations is similar to what was reported in SA- 71% https://t.co/4HvSdvPXQI @michaelzlin
lol
Not the information we want to hear, but isn't it better to deal with what is real in order to plan the future? (I'd rather hear that all vaccines were equally super effective)
NEW. From this new report. "Vaccine effectiveness against COVID-19 hospitalization during March 11–August 15, 2021, was higher for the Moderna vaccine (93%) than the Pfizer-BioNTech vaccine (88%) and the Janssen vaccine (71%)"
Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 https://t.co/L0sRYF7Rzd @CDCgo
RT @chrishendel: Just out via @CDCgov's @CDCMMWR Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (J&J) Vaccines in Pre…
MMWR: Comparative Effectiveness of Moderna, Pfizer-BioNTech, and Janssen (Johnson & Johnson) Vaccines in Preventing COVID-19 Hospitalizations Among Adults Without Immunocompromising Conditions — United States, March–August 2021 https://t.co/INZlcw47dY
New COVID-19 vaccine report directly from the CDC